Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
Editor’s note: Energy generation data is sourced from the Energy Information Administration. The breakdowns by source may not add up to renewable energy generation totals for each state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback